Log in

Pfizer tops 4Q expectations, starts low with 2023 forecast

The Associated Press
Posted 1/31/23

COVID-19 vaccine booster shots and treatments for the virus helped push Pfizer to a better-than-expected final quarter of 2022. The drugmaker also debuted on Tuesday a 2023 forecast that starts off …

This item is available in full to subscribers.

Please log in to continue

Log in